key: cord-0951375-zklols8j authors: Lagoumintzis, George; Chasapis, Christos T.; Alexandris, Nikolaos; Tzartos, Socrates; Eliopoulos, Elias; Farsalinos, Konstantinos; Poulas, Konstantinos title: COVID-19 and Cholinergic Anti-inflammatory Pathway: In silico Identification of an Interaction between α7 Nicotinic Acetylcholine Receptor and the Cryptic Epitopes of SARS-CoV and SARS-CoV-2 Spike Glycoproteins date: 2020-08-21 journal: bioRxiv DOI: 10.1101/2020.08.20.259747 sha: e1b97f41ae3d285a24dd57c93ae55b0750974ed2 doc_id: 951375 cord_uid: zklols8j SARS-CoV-2 is the coronavirus that originated in Wuhan in December 2019 and has spread globally. The observation of a low prevalence of smokers among hospitalized COVID-19 patients has led to the development of a hypothesis that nicotine could have protective effects by enhancing the cholinergic anti-inflammatory pathway. Based on clinical data and on modelling and docking experiments we have previously presented the potential interaction between SARS-CoV-2 Spike glycoprotein and nicotinic acetylcholine receptors (nAChRs), due to a “toxin-like” epitope on the Spike Glycoprotein, with homology to a sequence of a snake venom toxin. We here present that this epitope coincides with the well-described cryptic epitope for the human antibody CR3022 and with the epitope for the recently described COVA1-16 antibody. Both antibodies are recognizing neighboring epitopes, are not interfering with the ACE2 protein and are not able to inhibit SARS-CoV and SARS-CoV-2 infections. In this study we present the molecular complexes of both SARS-CoV and SARS-CoV-2 Spike Glycoproteins, at their open or closed conformations, with the molecular model of the human α7 nAChR. We found that the interface of all studied protein complexes involves a large part of the “toxin-like” sequences of SARS-CoV and SARS-CoV-2 Spike glycoproteins and toxin binding site of human α7 nAChR. Severe acute respiratory syndrome (SARS) is a viral respiratory disease caused by the SARSassociated coronavirus (SARS-CoV). In February 2003, SARS was first reported in Asia. The disease spread to countries in North America, South America, Europe, and Asia before the SARS global outbreak of 2003 was contained. No known cases of SARS were reported anywhere in the world after 2004 [1, 2] . In April 2003, rumors spread that smoking protected patients from developing SARS, which were rejected by the authorities [3] . Several studies suggested that smokers were under-represented among hospitalized SARS patients but no firm conclusions about the association between smoking and SARS-CoV infection were drawn [4] [5] [6] [7] . As the global pandemic of Corona Virus Disease 2019 (COVID-19), a disease caused by the acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is evolving, it is imperative to understand the pathophysiology and the risk and potentially protective factors associated with disease progression and severity in order to offer effective therapies. The association between smoking and COVID-19 is controversial. Several meta-analyses have identified an unusually low pooled prevalence of smoking compared to the population smoking rates [8, 9] . While limitations exist in these analyses, similar observations of low smoking prevalence among hospitalized COVID-19 patients have been observed in case series from many countries [10] . Cox et al. recently published a cohort study of 8.28 million participants, including 19, 486 confirmed COVID-19 cases, and found that smoking was associated with lower odds for COVID-19 diagnosis and ICU admission [11] . This apparently protective effect was stronger for heavy and moderate smokers. Other studies have shown that, once hospitalized, smokers are at higher risk for adverse outcomes [9, 12] . We hypothesized for the first time in early April 2020 that the Nicotinic Cholinergic System (NCS) could be involved in the pathophysiology of severe COVID-19 and we have recently expanded on this hypothesis [13, 14] . The NCS is an important pathway which regulates the response to inflammation. Its effects on macrophages and other immune cells are mainly regulated by the vagus nerve and by alpha7 nicotinic acetylcholine receptors (nAChRs) [15] . This so-called "cholinergic antiinflammatory pathway" has been found beneficial in preventing inflammatory conditions such as sepsis and Α cute Respiratory Distress Syndrome (ARDS) in animal models [16] . Dysregulation of the NCS could therefore be a possible cause for the uncontrolled inflammatory response in COVID-19. It could also explain other clinical manifestations of COVID-19 such as anosmia and thromboembolic complications [17] . We therefore hypothesized that SARS-CoV-2 may interact directly with the NCS [18] . reported that CR3022 binds to the RBD, and presented the crystal structure of the Fab/RBD complex at 2.4Å resolution [21] . The antibody's neutralizing potential is established for SARS-CoV but not for SARS-CoV-2, although it may exhibit some in vivo protection against the latter. Both groups recognized that the highly conserved and cryptic epitope for CR3022 is inaccessible in the prefusion Spike glycoprotein. Neither group could explain the exact function of this epitope, but both proposed that this cryptic epitope could be therapeutically 6 useful, possibly in synergy with an antibody that blocks ACE2 attachment. The aa that form this epitope are highly conserved in SARS-CoV and SARS-CoV-2. Of the 28 epitope residues (defined as residues buried by CR3022), 24 are preserved between SARS-CoV and SARS-CoV-2. This explains the CR3022 cross-reactivity to SARS-CoV and SARS-CoV-2 RBDs. Nevertheless, despite having high epitope residue conservation, CR3022 Fab binds to SARS-CoV RBD with much greater affinity than to SARS-CoV-2 RBD. CR3022's epitope does not overlap with the ACE2-binding site. Structural alignment of the CR3022-SARS-CoV-2 RBD complex with the ACE2-SARS-CoV-2 RBD complex further implies that CR3022 binding does not interfere with ACE2 [20] . This suggests that the neutralization mechanism of CR3022 for SARS-CoV is not based on direct blocking of receptor binding, which is consistent with the finding that CR3022 does not compete with ACE2 for binding to the RBD [22] . Liu et al. recently presented a SARS-CoV-2 specific antibody, called COVA1-16, isolated from a convalescent COVID-19 patient, which binds to the same epitope [23] . The affinity for SARS-CoV-2 Spike glycoprotein is higher, compared to the affinity for SARS-CoV Spike glycoprotein, as expected. In this study, we examined the potential interaction between α 7 nAChRs and SARS-CoV and SARS-CoV-2 Spike glycoproteins RBDs. For SARS-CoV-2 our previous study identified such an interaction located at aa 375-390, a region that is homologous to a sequence of the NL1 homologous neurotoxin which is a well-established NCS inhibitor [24, 25] . Interestingly this epitope is part of the cryptic epitope mentioned above for the human antibody CR3022 and COVA1-16 [20, 21, 23] . Having previously presented the 3D structural location of this conformations, ideally adopted by Spike glycoproteins. We compared aa sequences between SARS-CoV and SARS-CoV-2 Spike glycoproteins and snake venom neurotoxins. Sequence retrieval of the protein sequences of both virus-related Spike proteins and "three finger" neurotoxins from various species was performed using the National Center for Biotechnology Information (NCBI, Bethesda, MD, USA) databases. BLAST searches were performed using Mega BLAST [26] with the UNIPROT protein database [27] and by using BLASTP (protein-protein BLAST) with default parameters. Multiple sequence alignments were performed using ClustalOmega program (Clustal-O) [28] . The 3D structures of the SARS-CoV-2 Spike glycoprotein (S1) in complex with the human 8 The protein structure prediction of the ECD of human α 7 nAChR was performed using ROSETA software [29] , applying automated multi-step and multi-template homology modelling approach. The complexes between SARS-CoV and SARS-CoV-2 Spike 1 (S1) glycoprotein and ECD of the human pentameric α 7 nAChR were modelled using HADDOCK server [30] . The predicted interaction surfaces and the ambiguous interaction restrains (AIRs) which were used to drive HADDOCK process were automatically generated using WHISCY software. The input data for WHISCY prediction of the interaction surface between ECD of human pentameric α 7 nAChR and SARS-CoV and SARS-CoV-2 S1 glycoproteins were the conserved residues that were experimentally identified to be involved in the interaction between α 7 nAChR chimera and α -bungarotoxin. The binding affinity of biomolecular complexes were predicted using PRODIGY software [31] . All the protein structures are visualized using UCSF chimera software [32] . Figure 1A presents the sequence alignment of SARS-CoV and SARS-CoV-2 S1 glycoproteins (A7J8L4, P0DTC2) with Neurotoxin homolog NL1 (Q9DEQ3). We found a double "recombination" within the same S-protein sequence (aa 375-390), which is homologous in the Neurotoxin homolog NL1 sequence, part of the "three-finger" interacting importantly, this peptide is the main part of the epitope for the CR3022 antibody, as described before [20, 21] . The main interacting amino acids between the RBD of SARS-CoV and mAb CR3022, as described in the crystal structure of CR3022 and SARS-CoV-2 Spike This "toxin-like" fragment on SARS-CoV (aa 362-377) and SARS-CoV-2 (aa 375-390) RBD, containing an amphipathic sequence of alternating polar and hydrophobic amino acid residues with selectively charged amino acids in a conserved order, lies on the spike protein surface and is not buried in the domain core. The toxin-like sequence, in ball and stick representation, and its location in the protein surface is illustrated in Figure 2 . Neighboring the ACE2 binding motif, this entity may interact with the human α 7 nAChRs in a manner similar to neurotoxins. We have previously identified the interaction between the SARS-CoV-2 S1 glycoprotein (aa 381-386) and the α 9 subunit of nAChR ECD (aa 189-192), a region that forms the core of the nAChR "toxin-binding site". The interaction between the two proteins is caused by complementarity of the hydrogen bonds and shape [18] . The interaction mode is very similar to the interaction between α 9 nAChR and both α -bungarotoxin and the homologous neurotoxin NL1 (snake venom toxins are known to inhibit nAChRs). Similar interacting surfaces were observed between the SARS-CoV and SARS-CoV-2 S1 and the LBD of the pentameric α 7 nAChR chimera. Herein, the HADDOCK models show that the interface of all studied protein complexes involves the majority of the toxin like sequences within SARS-CoV S proteins and toxin binding site of human α 7 nAChR. The binding affinity (ΔG, expressed in kcal mol -1 ), the dissociation constant (K d at 25 , expressed in Molar), electrostatic energy (expressed in kcal mol -1 ) and the buried surface area (expressed in Å 2 ) for all the modelled protein complexes are presented in Table 1 . The dissociation constant of all SARS-α7 nAChR complexes found to be in the nM range, which is comparable with experimental supported Kds of well-known enzymatic interacting partners that produce stable protein complexes (i.e., E2-E3 pairs in ubiquitination pathway [33] ). Table 1 . Haddock parameters of SARS-CoV S1 and SARS-CoV-2 S1 with ECD of human α 7 nAChR pentamer. Open which binds to SARS-CoV-2 Spike glycoprotein to a similar region [23] . Most RNA viruses through antigenic mutation can avoid adaptive immunity of the host [35] . This is achieved due to the error-prone nature of RNA polymerases which induces sequence variation in each virus cycle replication, allowing frequent generation of mutant species [36] . Therefore, naturally occurring "epitopes" in viral antigens, usually targeted by neutralizing antibodies, are intrinsically subjected to antigenic variations. However, some proteins sites on the viral surface are less susceptible to mutation [37] [38] [39] . Such conserved regions are typically related to functions that are necessary for viral infection, such as receptor binding or membrane fusion, and are, therefore, less affected by antigenic variability [40] . Quite surprisingly, the cryptic epitope on the SARS-CoV and SARS-CoV-2 Spike glycoproteins is highly conserved and coincides with the toxin-like sequence interacting with nAChR. According to this hypothesis, CR3022, mutants of CR3022 with higher affinity to SARS-CoV-2 Spike glycoprotein and the COVA1-16 antibody can inhibit the interaction between Spike Glycoproteins and nicotinic cholinergic system. These in silico findings support our recently published hypothesis that SARS-CoV-2 could interact with nAChRs causing dysregulation of the NCS and the cholinergic antiinflammatory pathway. Such interactions may lead to uncontrolled immune response and cytokine storm, which is implicated in severe COVID-19 pathophysiology. Our efforts towards elucidating the potential molecular interactions between SARS-CoV-2 S glycoprotein and human nAChRs could provide a basis for accelerated vaccine, immunotherapy and diagnostic strategies against SARS-CoV-2 and other associated betacoronaviruses that could pose a major global human threat in the future. Severe acute respiratory syndrome: review and lessons of the 2003 outbreak Kong squashes SARS smoking 'cure' Smoking and Severe Acute Respiratory Syndrome Severe acute respiratory syndrome: clinical outcome and prognostic correlates A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis. Therapeutic Advances in Chronic Disease Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 -United States et alRisk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people Heart Published Online First: 31 Current Smoking is Not Associated with COVID-19 Smoking, vaping and hospitalization for COVID-19 Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system The inflammatory reflex Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation Expression and Function of the Cholinergic System in Immune Cells. Front Immunol Molecular Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications Simulations support the interaction of the SARS-CoV-2 spike protein with nicotinic acetylcholine receptors and suggest subtype specificity A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV Neutralization of SARS-CoV-2 by destruction of the prefusion Spike Cell Host & Microbe Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody Emerging Microbes & Infections Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity bioRxiv Snake and snail toxins acting on nicotinic acetylcholine receptors: fundamental aspects and medical applications Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity Basic Local Alignment Search Tool Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega Protocols for Molecular Modeling with Rosetta3 and RosettaScripts Modeling Protein-Protein Complexes Using the HADDOCK Webserver "Modeling Protein Complexes with HADDOCK PRODIGY: a web server for predicting the binding affinity of protein-protein complexes Software extensions to UCSF chimera for interactive visualization of large molecular assemblies NMR-based insights into the conformational and interaction properties of Arkadia RING-H2E3 Ub ligase Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19 Viral mechanisms of immune evasion Rates of evolutionary change in viruses: patterns and determinants A highly conserved epitope on the spike protein of infectious bronchitis virus Large-scale sequence analysis of hemagglutinin of influenza A virus identifies conserved regions suitable for targeting an antiviral response A highly conserved sequence associated with the HIV gp41loop region is an immunomodulator of antigen-specific T cells in mice Writing-Reviewing and Editing; ST: Methodology, Writing-Reviewing and Editing EE: Methodology, Software, Supervision; KF: Conceptualization, Reviewing results and data interpretation, Writing Original and final draft for financial support of the personnel.